Growth- Differentiation Factor-15 for Long-Term Risk Prediction in Patients Stabilized After an Episode of Non-ST-Segment-Elevation Acute Coronary Syndrome

被引:85
作者
Eggers, Kai M. [1 ,2 ]
Kempf, Tibor [3 ]
Lagerqvist, Bo [1 ,2 ]
Lindahl, Bertil [1 ,2 ]
Olofsson, Sylvia [1 ,2 ]
Jantzen, Franziska [3 ]
Peter, Timo [3 ]
Allhoff, Tim [3 ]
Siegbahn, Agneta [1 ,2 ]
Venge, Per [1 ,2 ]
Wollert, Kai C. [3 ]
Wallentin, Lars [1 ,2 ]
机构
[1] Univ Uppsala Hosp, Dept Med Sci, S-75185 Uppsala, Sweden
[2] Uppsala Clin Res Ctr, Uppsala, Sweden
[3] Hannover Med Sch, Dept Cardiol & Angiol, D-3000 Hannover, Germany
关键词
follow-up studies; prognosis; acute coronary syndrome; growth-differentiation factor-15; risk assessment; stable coronary artery disease; CHRONIC HEART-FAILURE; ARTERY-DISEASE; MYOCARDIAL-INFARCTION; PROGNOSTIC VALUE; NONINVASIVE STRATEGY; NATRIURETIC PEPTIDE; EUROPEAN-SOCIETY; RANDOMIZED-TRIAL; FOLLOW-UP; STRATIFICATION;
D O I
10.1161/CIRCGENETICS.109.877456
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background - Growth-differentiation factor-15 (GDF-15) has emerged as a prognostic biomarker in patients with non-ST-segment-elevation acute coronary syndrome. This study assessed the time course and the long-term prognostic relevance of GDF-15 levels measured repetitively in patients with non -ST-segment-elevation acute coronary syndrome during 6 months after the acute event. Methods and Results - GDF-15 and other biomarkers were measured at randomization, after 6 weeks, and after 3 and 6 months in 950 patients with non-ST-segment-elevation acute coronary syndrome included in the FRagmin and Fast Revascularization during InStability in Coronary artery disease II study. Study end points were death, recurrent myocardial infarction, and their composite during 5-year follow-up. Median GDF-15 levels decreased slightly from 1357 ng/L at randomization to 1302 ng/L at 6 months (P < 0.001). GDF-15 was consistently related to cardiovascular risk factors and biochemical markers of hemodynamic stress, renal dysfunction, and inflammation. Moreover, GDF-15 was independently related to the 5-year risk of the composite end point when measured at both 3 months (adjusted hazard ratio, 1.8 [1.0 to 3.0]) and 6 months (adjusted hazard ratio, 2.3 [1.3 to 4.1]). Serial measurements of GDF-15 at randomization and 6 months helped to identify patient cohorts at different levels of risk, with patients with persistently elevated GDF-15 levels > 1800 ng/L having the highest rate of the composite end point. Conclusions - GDF-15 is independently related to adverse events in non-ST-segment-elevation acute coronary syndrome both in the acute setting and for at least 6 months after clinical stabilization. Therefore, continued research on GDF-15 should be focused on the usefulness of GDF-15 for support of clinical management in acute and chronic ischemic heart disease. (Circ Cardiovasc Genet. 2010;3:88-96.)
引用
收藏
页码:88 / U284
页数:10
相关论文
共 25 条
[1]  
Anavekar NS, 2004, NEW ENGL J MED, V351, P1285, DOI 10.1056/NEJMoa041365
[2]  
[Anonymous], LANCET
[3]   European Society of Cardiology and American College of Cardiology guidelines for redefinition of myocardial infarction: How to use existing assays clinically and for clinical trials [J].
Apple, FS ;
Wu, AHB ;
Jaffe, AS .
AMERICAN HEART JOURNAL, 2002, 144 (06) :981-986
[4]  
Bassand JP, 2007, EUR HEART J, V28, P1598, DOI 10.1093/eurheartj/ehm161
[5]   Persistent cardiac troponin I elevation in stabilized patients after an episode of acute coronary syndrome predicts long-term mortality [J].
Eggers, Kai M. ;
Lagerqvist, Bo ;
Venge, Per ;
Wallentin, Lars ;
Lindahl, Bertil .
CIRCULATION, 2007, 116 (17) :1907-1914
[6]   Prognostic Value of Biomarkers During and After Non-ST-Segment Elevation Acute Coronary Syndrome [J].
Eggers, Kai M. ;
Lagerqvist, Bo ;
Venge, Per ;
Wallentin, Lars ;
Lindahl, Bertil .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 54 (04) :357-364
[7]   Gene expression pattern in biomechanically stretched cardiomyocytes - Evidence for a stretch-specific gene program [J].
Frank, Derk ;
Kuhn, Christian ;
Brors, Benedikt ;
Hanselmann, Christiane ;
Dde, Mark Lu ;
Katus, Hugo A. ;
Frey, Norbert .
HYPERTENSION, 2008, 51 (02) :309-318
[8]   Association of C-reactive protein and serum amyloid A with recurrent coronary events in stable patients after healing of acute myocardial infarction [J].
Harb, TS ;
Zareba, W ;
Moss, AJ ;
Ridker, PM ;
Marder, VJ ;
Rifai, N ;
Watelet, LFM ;
Arora, R ;
Brown, MW ;
Case, RB ;
Dwyer, EM ;
Gillespie, JA ;
Goldstein, RE ;
Greenberg, H ;
Hochman, J ;
Krone, RJ ;
Liang, CS ;
Lichstein, E ;
Little, W ;
Marcus, FI ;
Oakes, D ;
Sparks, CE ;
VanVoorhees, L .
AMERICAN JOURNAL OF CARDIOLOGY, 2002, 89 (02) :216-+
[9]   The transforming growth factor-β superfamily member growth-differentiation factor-15 protects the heart from ischemia/reperfusion injury [J].
Kempf, T ;
Eden, M ;
Strelau, J ;
Naguib, M ;
Willenbockel, C ;
Tongers, J ;
Heineke, J ;
Kotlarz, D ;
Xu, J ;
Molkentin, JD ;
Niessen, HW ;
Drexler, H ;
Wollert, KC .
CIRCULATION RESEARCH, 2006, 98 (03) :351-360
[10]   Growth-differentiation factor-15 improves risk stratification in ST-segment elevation myocardial infarction [J].
Kempf, Tibor ;
Bjoerklund, Erik ;
Olofsson, Sylvia ;
Lindahl, Bertil ;
Allhoff, Tim ;
Peter, Timo ;
Tongers, Jorn ;
Wollert, Kai C. ;
Wallentin, Lars .
EUROPEAN HEART JOURNAL, 2007, 28 (23) :2858-2865